Early Staphylcoccal and Other Bacterial Infections in CF
Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.
Number of Participants Being Recruited:
Single / Multi-Center:
STUDY BACKGROUND INFORMATION:
Chronic airway infections in patients with CF lead to progressive loss of lung function effecting quality and length of life. The most common bacteria found in the airway are Staphylococcal aureus, Pseudomonas aeruginosa, Hemophilus influenzae, and Burkholderia cepacia.
However, there may be other bacteria that are not identified with the current techniques for processing airway cultures. Little is known about early development of airway infections with multiple bacteria or the importance of other types of bacteria on disease progression in CF. Until recently, studies were limited by culture techniques that may miss multiple or difficult to culture bacteria . New techniques are now being used to characterize bacteria without the need for culture.
This study will use these techniques to identify multiple bacteria and other types of bacteria in airway samples from young CF children.
1 Days - 4 Years
P. aeruginosa status:
B. cepacia status:
Other Primary Eligibility Requirements:
Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific
trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.
The sites listed below are currently recruiting subjects. Please note that this list generally lists either the pediatric or adult program but not both even though both programs may be recruiting subjects. Also, this list does not include sites that may be participating in the study but are not yet open for recruitment. If you are interested in this study please contact your center for more information.